Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting

被引：0
|
作者：
Thomas M. Atkinson
Lauren J. Rogak
Narre Heon
Sean J. Ryan
Mary Shaw
Liora P. Stark
Antonia V. Bennett
Ethan Basch
Yuelin Li
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Psychiatry and Behavioral Sciences
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[3] City University of New York,undefined
[4] University of North Carolina-Chapel Hill,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2017年 / 143卷
关键词：
Patient-reported outcomes; Adverse events; Clinical trials; Clinician–patient agreement; Item response theory; Neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：735 / 743
页数：8
相关论文
共 50 条
  • [21] Differences between randomized clinical trial patients and real-world initiators of liraglutide
    Knudsen, Jakob S.
    Thomsen, Reimar W.
    Pottegard, Anton
    Baggesen, Lisbeth M.
    Knop, Filip
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 487 - 487
  • [22] Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
    Kudrow, David
    Krege, John H.
    Hundemer, Hans P.
    Berg, Paul H.
    Khanna, Rashna
    Ossipov, Michael H.
    Pozo-Rosich, Patricia
    HEADACHE, 2020, 60 (03): : 576 - 588
  • [23] DIFFERENCES IN POST-ERCP ADVERSE EVENT RATES BETWEEN POST-LIVER TRANSPLANT PATIENTS AND PATIENTS WITH NATIVE HEPATOBILIARY ANATOMY
    Catron, Tom D.
    Shipley, Lindsey
    Johnson, Dane
    Mitchell, Rachell
    Harrison, Devin S.
    Baig, Kondal Kyanam Kabir
    Shoreibah, Mohamed G.
    Ahmed, Ali M.
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB211 - AB212
  • [24] Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis
    He, Xiaobo
    Cheng, Xiao
    Feng, Xudong
    Wan, Hong
    Chen, Sihan
    Xiong, Maoming
    FRONTIERS IN PUBLIC HEALTH, 2021, 8
  • [25] Brazilian clinical trial of uniform multidrug therapy for leprosy patients - the correlation between clinical disease types and adverse effects
    Goncalves, Heitor de Sa
    de Andrade Pontes, Maria Araci
    Buehrer-Sekula, Samira
    Cruz, Rossilene
    Almeida, Paulo Cesar
    Amaral de Moraes, Maria Elisabete
    Penna, Gerson Oliveira
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2012, 107 : 74 - 78
  • [26] Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff
    Kennedy, Fiona
    Shearsmith, Leanne
    Ayres, Michael
    Lindner, Oana C.
    Marston, Lewis
    Pass, Alison
    Danson, Sarah
    Velikova, Galina
    CLINICAL TRIALS, 2021, 18 (02) : 168 - 179
  • [27] Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
    Ewer, Michael S.
    Herson, Jay
    CARDIO-ONCOLOGY, 2022, 8 (01)
  • [28] Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
    Michael S. Ewer
    Jay Herson
    Cardio-Oncology, 8
  • [29] REVIEWING ADVERSE DRUG EVENT REPORTING BETWEEN RANDOMIZED CLINICAL TRIAL DATA AND REAL WORLD POST MARKET DATA FOR SORAFENIB AND SUNITINIB
    Grothen, A. E.
    Rivera, D. R.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [30] Trial participation as a determinant of clinical outcome: Differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiology
    de Boer, Sanneke P. M.
    van Leeuwen, Maarten A. H.
    Cheng, Jin M.
    Oemrawsingh, Rohit M.
    van Geuns, Robert-Jan
    Serruys, Patrick W. J. C.
    Boersma, Eric
    Lenzen, Mattie J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 169 (04) : 305 - 310
12345